Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2018 Dec 14;37:315. doi: 10.1186/s13046-018-1000-3

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s). 2018

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

PMC Copyright notice

Fig. 1 — Correlation between Dab2 expression and lung cancer clinical characteristics as well as lung cancer patients’ outcome. a High cytoplasmic expression of Dab2 in well-differentiated adenocarcinoma cells (a, IHC, 400×); Negative expression of Dab2 in poorly-differentiated adenocarcinoma cells (b, IHC, 400×); Medium cytoplasmic and strong nuclear expression of Dab2 in well-differentiated squamous cell carcinoma cells (c, IHC, 400×); Negative expression of Dab2 in poorly-differentiated squamous cell carcinoma cells (d, IHC, 400×). b Kaplan-Meier analysis demonstrates that low Dab2 expression is positively correlated with poor outcome of lung cancer patients (P < 0.05)